" /> Peroxisome biogenesis disorder 4a (zellweger) - CISMeF





Preferred Label : Peroxisome biogenesis disorder 4a (zellweger);

Symbol : PBD4A;

CISMeF acronym : CGC; CG4; CG6; PBD4A;

Type : Phenotype, molecular basis known;

Included titles and symbols : Peroxisome biogenesis disorder, complementation group 4; Peroxisome biogenesis disorder, complementation group 6; Peroxisome biogenesis disorder, Complementation group C; CG4; CG6; CGC;

Description : The peroxisomal biogenesis disorder (PBD) Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006). For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100. Individuals with PBDs of complementation group 4 (CG4, equivalent to CG6 and CGC) have mutations in the PEX6 gene. For information on the history of PBD complementation groups, see 214100.;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the peroxisome biogenesis factor 6 gene (PEX6, 601498.0001);

Laboratory abnormalities : Zellweger complementation group C; Absence of peroxisomes; Zellweger complementation group 4; Elevated serum very long chain fatty acids (VLCFA);

Prefixed ID : #614862;

Details


You can consult :


Nous contacter.
25/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.